BILL ANALYSIS
HR8943
BEARISHOur Doctors First Act of 2026
HR8943 (Our Doctors First Act of 2026) has been assessed with a bearish outlook for investors. This legislation directly affects HCA Healthcare ($HCA), $UHS and $THC. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.
bearish
Market Sentiment
3
Affected Stocks
1
Sectors Impacted
Key Takeaways for Investors
Bill is early-stage with low passage probability
No direct funding or tax changes; restricts existing Medicare GME payments
For-profit hospital operators face modest operational risk if enacted
How HR8943 Affects the Market
The bill has minimal market implications at this stage. If it gains traction, for-profit hospital operators like HCA, UHS, and THC could face increased labor costs from replacing non-citizen residents, but the effect on earnings would be small (less than 1% of revenue). No bullish signals for any sector.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR8943 |
| Market Sentiment | bearish |
| Event Date | |
| Affected Sectors | Healthcare |
| Affected Stocks | HCA Healthcare ($HCA), $UHS, $THC |
| Source | View on Congress.gov → |
Summary
HR8943 (Our Doctors First Act) would ban Medicare GME payments for non-citizen residents, imposing penalties on hospitals. The bill is in early committee stage with no companion Senate bill, making passage unlikely. For-profit hospital operators HCA, UHS, and THC face modest operational risk if enacted, but no near-term market impact.